Press

FILTER:

Boston Micro Fabrication: Mega Results From Producing Micro Parts

With new and innovative techniques for 3D printing/additive manufacturing continuing to emerge, MCAD Cafe recently interviewed John Kawola, CEO of Boston Micro Fabrication, a unique company that specializes in (as its name implies), micro components and machines that produce them.

Applications for Micro 3D Printing in the world of AR/VR

As technology evolves, we see amazing results arising from the convergence of many types of innovation. The combination of hardware and software advances has resulted in creating an entirely new world – one that hovers between reality and fantasy.

AR/VR Magazine Podcast Episode #5 – John Kawola from Boston Micro Fabrication

In Episode #5 of the AR/VR Magazine Podcast, we interview John Kawola, who is the CEO of Boston Micro Fabrication, which is a manufacturer of micro 3D printers. John talks about BMF’s patented 3D printing technology called Projection Micro Stereolithography or PULSE, as well as various applications for Micro 3D Printing for the immersive technology hardware industry.

Micro 3D printed needles and the market for μ-resolution 3D printing

Last month, researchers at Carnegie Mellon University’s College of Engineering and the University of Pittsburgh’s School of Medicine demonstrated a 3D printed microneedle array platform capable of delivering vaccines directly into the skin, with the particular goal of improving COVID-19 vaccine delivery in the developing world.

Micro 3D Printing For Emerging MEMS And Microfluidics Applications

Last month, researchers at Carnegie Mellon University’s College of Engineering and the University of Pittsburgh’s School of Medicine demonstrated a 3D printed microneedle array platform capable of delivering vaccines directly into the skin, with the particular goal of improving COVID-19 vaccine delivery in the developing world.

Scalable manufacturing for novel, painless vaccine delivery

Collaborators led by Carnegie Mellon University are developing a novel approach to COVID-19 inoculation that addresses both immunological effectiveness and manufacturing efficiency with a low-dose, inexpensive, hybrid microneedle array (Hybrid-MNA) technology.